Category: Diagnostics

Analogic's medical business flat in Q2

March 10, 2010 by MassDevice staff

Analogic Corp.'s (NSDQ:ALOG) largest business segment posted flat sales, with a 9 percent dip in its bread-and-butter MRI and CT equipment business offsetting stronger sales of specialized ultrasound equipment.

The Peabody, Mass.-based imaging equipment maker posted sales of $103.3 million for the three months ended Jan. 31, essentially flat compared with $102.7 million during the same period last year. Still, net income improved to $3.6 million, compared to $1.4 million for the same period last year, when the company took a $3.5 million hit to its bottom line when it laid off 145 employees, or about 9 percent of its total workforce.

BG Medicine, Abbott partner on heart attack mortality test

March 9, 2010 by MassDevice staff

BG Medicine Inc. signed a deal to develop its heart attack mortality test for use in a handheld blood analyzer made by medical device giant Abbott Laboratories (NYSE:ABT).

Waltham, Mass.-based BG said it will develop its galectin-3 biomarker for use in the Abbott Point of Care i-STAT System, a handheld diagnostic tool that provides real-time blood results.

Rcadia wins CE Mark for imaging software

March 8, 2010 by MassDevice staff

Rcadia Medical Imaging Ltd. has received CE Mark approval for its algorithm-based software tool that detects for signs of coronary artery disease.

The Newton, Mass.-based company manufactures the COR Analyzer, which quickly triages patients who come into an emergency room with chest pains to determine if there are signs of coronary artery disease. The software uses an algorithm to rapidly processes images taken during coronary CT angiography (cCTA) studies and produces real-time analysis to determine whether there are lesions in coronary arteries.

The product is specifically for use in emergency departments and radiology settings and functions as an add-on to all models of cCTA machines.

Biospace Med wins FDA clearance for X-ray station

March 8, 2010 by MassDevice staff

Biospace Med won regulatory clearance to use its full-body, low-radiation X-ray workstation for children with spinal problems.

The Paris, France-based company, which houses its U.S. headquarters in Cambridge, Mass., won 510(k) clearance from the Food & Drug Administration to use its sterEOS 2D/3D workstation in pediatric care.

The device, which consists of a scanner and a three-dimensional bone-modeling program, can capture head-to-toe images of patients in a standing, weight-bearing position, which can help orthopedic surgeons determine balance, posture and the position of each vertebra. The company says the workstation enables better assessments for surgical planning.

Interleukin raises $5 million

March 5, 2010 by MassDevice staff

Interleukin Genetics Inc. (NYSE:ILI) drummed up about $5.3 million in commitments from institutional investors in a registered direct offering.

Update: Isis Biopolymer raises another $3 million

March 3, 2010 by MassDevice staff

Isis Biopolymer Inc., a company developing a new generation of non-invasive drug delivery patches, has raised $3 million through an equity sale to existing investors.

The Providence, R.I.-based firm has developed the Isis Patch, a compact, wireless, active iontophoretic patch using a design that implements advances in microprocessors, thin film batteries, biopolymers and adhesives.

In a statement sent to MassDevice, CEO Emma Durand said the current round "clearly shows the confidence of the investment community in Isis Biopolymer and our innovative transdermal drug delivery and biosensor technology."